Antipsoriatics
- Name
- Antipsoriatics
- Accession Number
- DBCAT002154 (DBCAT001937)
- Description
Not Available
- ATC Classification
- Drugs
Drug Drug Description Secukinumab An immunomodulating agent and interleukin antagonist used to manage plaque psoriasis, psoriatic arthritis, ankylosing spondylitis, along with other joint inflammatory disorders. Calcitriol An active metabolite of vitamin D that is used to treat hyperparathyroidism and is also used in dialysis patients to combat hypocalcemia. Acitretin An oral retinoid used in the treatment of severe psoriasis. Methoxsalen A furocoumarin used to treat psoriasis and vitiligo. Tazarotene An acetylenic retinoid used to treat fine wrinkles, mottled pigmentation of the skin, acne vulgaris, and plaque psoriasis. Etretinate For the treatment of severe psoriasis in adults. Fumaric acid Not Available Calcipotriol A topical synthetic vitamin D2 derivative used in the treatment of plaque psoriasis. Trioxsalen A psoralen derivative that has been used in combination with UV light to treat vitiligo, but has been discontinued by its manufacturer. Anthralin An anthracene used to treat stable plaque psoriasis. Bergapten Bergapten is under investigation in clinical trial NCT00533195 (Comparison of UVA1 Phototherapy Versus Photochemotherapy for Patients With Severe Generalized Atopic Dermatitis). Tacalcitol A vitamin D analog indicated in the treatment of mild to moderate plaque psoriasis. Ulobetasol A lipocortin corticosteroid used to treat inflammatory and pruritic corticosteroid-responsive dermatoses. - Drugs & Drug Targets